UNC alum, pharmaceutical exec Fred Eshelman makes another investment: experimental cancer treatment
Posted Apr 28, 2015
Fred Eshelman made another move by joining a group that invested $28 million in Innocrin Pharmaceuticals, a company developing treatments for breast and prostate cancers. Eshelman, who recently founded Eshelman Ventures, also joined Innocrin's board.
(Triangle Business Journal)
Related: Campus Connections
Tar Heels Top Their Best Multi-Year Graduation Success Rate For Fifth Straight YearUNC student-athletes established their highest multi-year graduation rates for the fifth straight year and set the record for the best single-year rate as reported in...
Thu Nov 21, 2024Clouds Brewing opens new location on Franklin Street, replacing Gizmo Brew Works
Clouds Brewing, a Triangle-based brewery, opened a third location on Franklin Street, replacing the space previously occupied by Gizmo Brew Works. On August 14, Gizmo...
Wed Nov 20, 2024
20 Years of the Carolina Covenant
Established in 2004, the Carolina Covenant is a financial aid package and network of support that provides an opportunity for students to graduate from the...
Sun Nov 17, 2024
10 things every UNC fan must do when visiting Chapel Hill
Locals call it Blue Heaven and it doesn’t take long to understand why. Virtually everything in town is painted the color of the sky. Even...
Fri Nov 15, 2024